Volitionrx (VNRX) Consolidated Net Income (2012 - 2026)
Volitionrx's (VNRX) quarterly Consolidated Net Income came in at $260595.0 in Q4 2025, down 49.54% YoY from $516444.0 in Q4 2024, and up 929.05% on a QoQ basis from -$31433.0 in Q3 2025.
Volitionrx (VNRX) Consolidated Net Income (2012 - 2026) Analysis & Trends
Volitionrx (VNRX) has 10 years of Consolidated Net Income data on file, last reported at $260595.0 in Q4 2025.
- Quarterly Consolidated Net Income fell 49.54% year-over-year to $260595.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.7 million (up 31.64% YoY) and the FY2025 annual result came in at $146302.0, down 49.58% from the prior year.
- Consolidated Net Income advanced to $260595.0 in Q4 2025, from -$31433.0 in the prior quarter.
- In the past five years, Consolidated Net Income ranged from a high of $516444.0 in Q4 2024 to a low of -$10.1 million in Q2 2023.
- A 5-year average of -$2.6 million and a median of $37528.5 in 2021 frame the typical range for Consolidated Net Income.
- Annual changes were most pronounced in 2022 — Consolidated Net Income surged 791.1% — and 2023, when it slumped 13369.88%.
- Tracing VNRX's Consolidated Net Income over 5 years: stood at $73088.0 in 2021, then advanced by 28.74% to $94092.0 in 2022, then plunged by 9442.17% to -$8.8 million in 2023, then surged by 105.88% to $516444.0 in 2024, then sank by 49.54% to $260595.0 in 2025.
- The last three Consolidated Net Income figures came in at $260595.0 (Q4 2025), -$31433.0 (Q3 2025), and $29992.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Volitionrx | 1.22 Mn | -1.58 Mn | - | -4.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -4.90 Mn |
| Dec 31, 2025 | 260,595.00 |
| Sep 30, 2025 | -31,433.00 |
| Jun 30, 2025 | 29,992.00 |
| Mar 31, 2025 | -5.94 Mn |
| Dec 31, 2024 | 516,444.00 |
| Sep 30, 2024 | -47,049.00 |
| Jun 30, 2024 | 74,629.00 |
| Mar 31, 2024 | -8.85 Mn |
| Dec 31, 2023 | -8.79 Mn |
| Sep 30, 2023 | -9.20 Mn |
| Jun 30, 2023 | -10.10 Mn |
| Mar 31, 2023 | -9.63 Mn |
| Dec 31, 2022 | 94,092.00 |
| Sep 30, 2022 | 69,305.00 |
| Jun 30, 2022 | 82,302.00 |
| Mar 31, 2022 | 83,977.00 |
| Dec 31, 2021 | 73,088.00 |
| Sep 30, 2021 | 45,065.00 |
| Jun 30, 2021 | 47,539.00 |